Buntanetap clinical trials
Also written Posiphen.
Includes 1 study of Buntanetap tartrate.
How each study uses buntanetap is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the buntanetap studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Annovis Bio Inc. (8)
Studies
Open first, then newest update. How each study uses buntanetap is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Study of Buntanetap in Participants With PDRecruitingPhase 2/3Annovis Bio Inc.NCT07284784Written as buntanetap/posiphen
- An Open-label Long-term Safety Study of Buntanetap in Participants With ADNot yet recruitingPhase 2/3Annovis Bio Inc.NCT07757204Written as buntanetap/posiphen
- A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADActive, not recruitingPhase 3Annovis Bio Inc.NCT06709014Written as buntanetap/posiphen
- A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADCompletedPhase 2/3Annovis Bio Inc.NCT05686044Written as Buntanetap/Posiphen
- A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDCompletedPhase 3Annovis Bio Inc.NCT05357989Written as buntanetap/posiphen
- Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's DiseaseCompletedPhase 1/2Annovis Bio Inc.NCT02925650Written as Posiphen
- Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's PatientsCompletedPhase 1/2Annovis Bio Inc.NCT04524351Written as Posiphen
- Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive ImpairmentTerminatedPhase 1Annovis Bio Inc.NCT01072812Written as Posiphen® tartrate capsules
Codes
What other systems call buntanetap · ClinicalTrials.gg INT035298
- UNII (FDA) Z0O4TJ588OBUNTANETAPOne source FDA
- NCI Thesaurus C188666BuntanetapOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Z0O4TJ588O | BUNTANETAP | One source FDA |
| NCI Thesaurus | C188666 | Buntanetap | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.